Cart
sales@molnova.com
Home - Products - Cell Cycle/DNA Damage - DNA/RNA Synthesis - SR15006

SR15006

CAS No. 2505001-54-5

SR15006( —— )

Catalog No. M28507 CAS No. 2505001-54-5

SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 Get Quote
5MG 50 Get Quote
10MG 87 Get Quote
25MG 178 Get Quote
50MG 335 Get Quote
100MG 500 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    SR15006
  • Note
    Research use only, not for human use.
  • Brief Description
    SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).
  • Description
    SR15006 is Krüppel-like factor 5 (KLF5) inhibitor (IC50 = 41.6 nM).(In Vitro):In DLD-1 CRC cells, SR15006 (1 μM or 10 μM) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
  • In Vitro
    SR15006 (1 μM or 10 μM; DLD-1 CRC cells) causes a significant reduction in the levels of tested cyclins over the course of 72 hours.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2505001-54-5
  • Formula Weight
    385.87
  • Molecular Formula
    C16H20ClN3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (259.15 mM)
  • SMILES
    O=C(C=CC=1C=CC=C(Cl)C1)NCC(=O)N2CCN(CC2)S(=O)(=O)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Blasticidin S HCl

    Blasticidin S HCl is a nucleoside antibiotic isolated from Stretomyces girseochromogenes and acts as a DNA and protein synthesis inhibitor.

  • JH-RE-06

    JH-RE-06 disrupts mutagenic translesion synthesis (TLS) by preventing the recruitment of mutagenic POLζ. JH-RE-06 is an effective REV1-REV7 interface inhibitor (IC50=0.78 μM; Kd=0.42 μM), which targets REV1 that interacts with the REV7 subunit of POLζ. JH-RE-06 also improves chemotherapy.

  • Cytembena

    Cytembena is a cytostatic and a carcinogenic compound that may increase the incidence of fibroadenomas.Cytembena broadly inhibits DNA biosynthesis.

Sign In Join Free